摘要
目的 研究肿瘤干细胞（BTSCs）致敏的树突状细胞（DCs）疫苗对颅内荷瘤小鼠的治疗作用.方法 无血清培养基中加入表皮生长因子和碱性成纤维细胞生长因子,将C6胶质瘤细胞诱导成胶质瘤干细胞,以此致敏大鼠骨髓来源的树突状细胞制备疫苗;立体定向建立大鼠颅内C6胶质瘤模型,分为A、B、C、D四组.每组分别经尾静脉注射1×107BTSCs致敏的DCs（DCs-BTSCs）、1×107 C6胶质瘤细胞致敏的DCs（DCs-C6）、1×107DCs及PBS,Kaplan-Meier法对大鼠生存情况进行分析,大鼠脑组织标本行HE染色及免疫组化分析.结果 胶质瘤干细胞CD133＋及nestin染色阳性;DCs具有典型的树突状结构,特异性标志OX62＋表达阳性;生存时间A组较其他组明显延长,Log-rank检验差异有统计学意义（P＜0.05）;A组HE染色炎性细胞浸润最多,免疫组化可见较多的CD8＋T淋巴细胞.结论 肿瘤干细胞致敏的树突状细胞疫苗能明显提高机体对胶质瘤的免疫力,其作用优于胶质瘤细胞致敏的树突状细胞疫苗,为树突状细胞疫苗的临床应用提供了新的依据.
Objective To investigate the effect of dendritic cells pulsed with brain tumor stem cells which are used to treat on intracranial glioma.MethodWe obtained murine brain tumor stem cells by growing C6 cells in epidermal growth factor/basic fibroblast growth factor without serum.Dendritic cells isolated from rat bone marrow were pulsed with BTSCs.Rat brain glioma models were established by stereotactic technique.107 DCs pulsed with BTSCs and C6 were injected through tail vein in group A and group B respectively.The same number of DCs and the same volume PBS were applied to group C and group D.The survival time of rats was analyzed by Log- rank survival analysis.Tumor samples were examinedwithHE staining and immunohistochemistry.Methods BTSCs expressedCD133 ＋ and nestin.DCs appeared typical long dentrite in morphology and expressed OX62＋ markers.The survival analysis showed group A was statistically significant in constrast to the other goups （P〈0.05）.The tumors in group A have the most inflammation and CD8 ＋ T lymphocytes.Concluion DCs loading with BTSCs lysates can provide a higher level of immunity protect against gliomas than those loading with C6 cells,which provide a new method in the immuntherapy of brain glioma.
出处
《中华神经外科杂志》
CSCD
北大核心
2011年第2期136-139,共4页
Chinese Journal of Neurosurgery
基金
山东省自然基金（Y2007C108）
教育部博士点基金（200804220042）
